EMTRICITABINE/TENOFOVIR ALAFENAMIDE TABLETS 200 Film-Coated Tablet Kenya - English - Pharmacy and Poisons Board

emtricitabine/tenofovir alafenamide tablets 200 film-coated tablet

mylan laboratories limited plot no.564/a/22, road no.92, jubilee hills, - emtricitabine/ tenofovir alafenamide fumarate - film-coated tablet - emtricitabine 200 mg/tenofovir alafenamide… - emtricitabine and tenofovir alafenamide

TAFICITA (Emtricitabine and Tenofovir Alafenamide Film Coated Tablets 200mg25mg) Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

taficita (emtricitabine and tenofovir alafenamide film coated tablets 200mg25mg)

mylan healthcare sdn. bhd. - emtricitabine; tenofovir alafenamide fumarate -

Descovy® (emtricitabine 200 mg tenofovir alafenamide 25 mg) film-coated tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

descovy® (emtricitabine 200 mg tenofovir alafenamide 25 mg) film-coated tablets

gilead sciences malaysia sdn. bhd. - emtricitabine; tenofovir alafenamide fumarate -

DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

descovy 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle

gilead sciences pty ltd - emtricitabine, quantity: 200 mg; tenofovir alafenamide fumarate, quantity: 11.2 mg (equivalent: tenofovir alafenamide, qty 10 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; microcrystalline cellulose; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; iron oxide black - treatment of hiv-1 infection: descovy is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25kg. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of descovy (see section 5.1 pharmacodynamic properties).,hiv-1 pre-exposure prophylaxis: descovy is indicated for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in at-risk adults and adolescents weighing at least 35 kg, excluding individuals at risk from receptive vaginal sex.

DESCOVY 200 mg/25 mg (200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

descovy 200 mg/25 mg (200 mg emtricitabine/25 mg tenofovir alafenamide) tablet bottle

gilead sciences pty ltd - emtricitabine, quantity: 200 mg; tenofovir alafenamide fumarate, quantity: 28 mg (equivalent: tenofovir alafenamide, qty 25 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; microcrystalline cellulose; magnesium stearate; titanium dioxide; purified talc; polyvinyl alcohol; macrogol 3350; indigo carmine aluminium lake - treatment of hiv-1 infection: descovy is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection in adults and paediatric patients weighing at least 25kg. the patients must not have a history of treatment failure or known mutations associated with resistance to the individual components of descovy (see section 5.1 pharmacodynamic properties).,hiv-1 pre-exposure prophylaxis: descovy is indicated for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in at-risk adults and adolescents weighing at least 35 kg, excluding individuals at risk from receptive vaginal sex.

Descovy® (emtricitabine 200 mg tenofovir alafenamide 10 mg) film-coated tablets Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

descovy® (emtricitabine 200 mg tenofovir alafenamide 10 mg) film-coated tablets

gilead sciences malaysia sdn. bhd. - tenofovir alafenamide fumarate; emtricitabine -

DESCOVY 200 MG10 MG Israel - English - Ministry of Health

descovy 200 mg10 mg

gilead sciences israel ltd - emtricitabine; tenofovir alafenamide fumarate - film coated tablets - tenofovir alafenamide fumarate 10 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv 1).בקשה לשינוי התוויה: 14/8/19addition of new info to posology section: patients undergoing haemodialysis

DESCOVY 200 MG25 MG Israel - English - Ministry of Health

descovy 200 mg25 mg

gilead sciences israel ltd - emtricitabine; tenofovir alafenamide fumarate - film coated tablets - tenofovir alafenamide fumarate 25 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv 1).בקשה לשינוי התוויה: 14/8/19addition of new info to posology section: patients undergoing haemodialysis

DESCOVY 200 MG10 MG Israel - English - Ministry of Health

descovy 200 mg10 mg

gilead sciences israel ltd - emtricitabine; tenofovir alafenamide fumarate - film coated tablets - tenofovir alafenamide fumarate 10 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv 1).

DESCOVY 200 MG25 MG Israel - English - Ministry of Health

descovy 200 mg25 mg

gilead sciences israel ltd - emtricitabine; tenofovir alafenamide fumarate - film coated tablets - tenofovir alafenamide fumarate 25 mg; emtricitabine 200 mg - tenofovir disoproxil and emtricitabine - descovy is indicated in combination with other antiretroviral agents for the treatment of adults and adolescents (aged 12 years and older with body weight at least 35 kg) infected with human immunodeficiency virus type 1 (hiv 1).